v3.26.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2026
Revenue Recognition [Abstract]  
Schedule of Disaggregated Revenue
Net Sales by Business
Three Months
2026
2025
MedSurg and Neurotechnology:
Instruments
$920
$838
Endoscopy
868
867
Medical
902
945
Vascular
517
406
$3,207
$3,056
Orthopaedics:
Knees
$670
$639
Hips
460
443
Trauma and Extremities
1,035
945
Ortho Tech
646
617
Spinal Implants
2
166
$2,813
$2,810
Total
$6,020
$5,866
Net Sales by Geography
Three Months 2026
Three Months 2025
United
States
International
United
States
International
MedSurg and Neurotechnology:
Instruments
$766
$154
$702
$136
Endoscopy
701
167
710
157
Medical
747
155
802
143
Vascular
280
237
203
203
$2,494
$713
$2,417
$639
Orthopaedics:
Knees
$472
$198
$464
$175
Hips
276
184
269
174
Trauma and Extremities
767
268
713
232
Ortho Tech
467
179
459
158
Spinal Implants
2
118
48
$1,982
$831
$2,023
$787
Total
$4,476
$1,544
$4,440
$1,426
Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes in contract liabilities during the three months 2026 were
as follows:
March 31
2026
Beginning contract liabilities
$1,024
Revenue recognized from beginning of year contract liabilities
(288)
Net advance consideration received during the period
299
Ending contract liabilities
$1,035